Icatibant for the treatment of orolingual angioedema following the administration of tissue plasminogen activator - 06/06/18
Doi : 10.1016/j.ajem.2018.03.018
Emily Brown, PharmD a, Christina Campana, DO b, ⁎ 
, Jacob Zimmerman, PharmD BCCCP a, Steven Brooks, MD c
, Jacob Zimmerman, PharmD BCCCP a, Steven Brooks, MD c a Department of Pharmacy, Cleveland Clinic Akron General, 1 Akron General Avenue, Akron, OH 44307, United States
b Department of Emergency Medicine, Northeast Ohio Medical University, Cleveland Clinic Akron General, 1 Akron General Avenue, Akron, OH 44307, United States
c Department of Emergency Medicine, Cleveland Clinic Akron General, 1 Akron General Avenue, Akron, OH 44307, United States
⁎Corresponding author at: 4960 Shady Brooke Run, Medina, OH 44256, United States.4960 Shady Brooke RunMedinaOH44256United States
Keywords : Icatibant, Angioedema, Tissue plasminogen activator, Stroke, Airway management
Plan
| ☆ | This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. |
© 2018
Elsevier Inc. Tous droits réservés.
Vol 36 - N° 6
P. 1125.e1-1125.e2 - juin 2018 Retour au numéro
Article précédent
- Acute bilateral retinal artery occlusion causing sudden blindness in 25-year-old patient
- Lauren Murphy, Gerard Carroll
- Alpha lipoic acid intoxicat?on: An adult
- Duygu Ferek Emir, Ibrahim Ulas Ozturan, Serkan Yilmaz
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?